How real are patients in placebo-controlled studies of acute manic episode?

European Neuropsychopharmacology

Volumn 14, Issue 4, 2004, Pages 319-323

  Storosum, Jitschak G ^a,b   Fouwels, Annemarie ^a   Gispen De Wied, Christine C ^a   Wohlfarth, Tamar ^b   Van Zwieten, Barbara J ^a   Van Den Brink, Wim ^b  

^a Med Eval Bd of the Netherlands   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Contraceptives; Manic episode; Placebo controlled

Indexed keywords

CONTRACEPTIVE AGENT; PLACEBO;

ALCOHOL ABUSE; ARTICLE; CLINICAL TRIAL; DRUG ABUSE; HUMAN; MANIA; NEUROLOGIC DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; SUICIDE ATTEMPT;

ADOLESCENT; ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES;

EID: 2442542994     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2003.10.003     Document Type: Article

References (19)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. 1987;American Psychiatric Association, Washington, DC. Revised
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Association, Washington, DC
3. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G., et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA. 271:1994;918-924
4. Cassidy F., Ahearn E.P., Carroll B.J. Substance abuse in bipolar disorder. Bipolar Disord. 4:2001;181-188
5. EMEA. Guidance for companies requesting scientific advice, London, January 2002. Rev. 1, EMEA/H/4260/01. http://www.emea.eu.int/htms/human/ sciadvice/index.htm.
6. Frye M.A., Altshuler L.L., McElroy S.L., Keck P.E., Denicoff K.D., Nolen W.A., Kupka R., Leverich G.S., Pollio C., Grunze H., Walden J., Post R.M. Gender differences in prevalence, risk, and clinical correlates of alcohol comorbidity in bipolar disorder. Am. J. Psychiatry. 160:2003;883-889
7. Hofer A., Hummer M., Huber R., Kurz M., Walch T., Fleischhacker W. Selection bias in clinical trials with antipsychotics. J. Clin. Psychopharmacol. 220:2000;699-702
8. Keck P.E., Versiani M., Potkin S., West S.A., Giller E., Ice K. Ziprasidone in Mania Study Group Ziprasidone in the treatment of acute bipolar manic: a three-week, placebo-controlled double-blind, randomized trial. Am. J. Psychiatry. 160:2003;741-748
9. McElroy S.L., Altshuler L.L., Suppes T., Keck P.E., Frye M.A., Denicot K.D., Nolen W.A., Kupka R.W., Leverich G.S., Rochussen J.R., et al. Axis I psychiatric comorbidity and its relationship to historic illness variables in 288 patients with bipolar disorder. Am. J. Psychiatry. 158:2001;420-426
10. Pope H.G. Jr., McElroy S.L., Keck P.E. Jr., Hudson J.I. Valproate in the treatment of acute mania. A placebo-controlled study. Arch. Gen. Psychiatry. 48:1991;62-68
11. Posternak M.A., Keitner G.I., Miller I.W. A reevaluation of the exclusion criteria used in antidepressant efficacy trials. Am. J. Psychiatry. 159:2002;191-200
12. Spearing M.K., Post R.M., Leverich G.S., Brandt D., Nolen W. Modification of the clinical global impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 73:1997;159-171
13. Spitzer R.L., Endicott J., Robbins E. Research Diagnositic Criteria (RDC) for a Selective Group of Functional Disorders. 2nd ed. 1975;New York State Psychiatric Institute, New York NY
14. Storosum J., van Zwieten B.J., de Haan L. Informed consent from behaviourally disturbed patients. Lancet. 359:2002;83
15. Tohen M., Greenfield S.F., Weiss R.D., Zarate C.A. Jr., Vagge L.M. The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harv. Rev. Psychiatry. 6:1998;133-141
16. Tohen M., Sanger T.M., McElroy S.L., Tollefson G.D., Chengappa K.N., Daniel D.G., Petty F., Centorrino F., Wang R., Grundy S.L., Greaney M.G., Jacobs T.G., David S.R., Jacobs T.G. Olanzapine HGEH Study Group Olanzapine versus placebo in the treatment of acute mania. Am. J. Psychiatry. 156:1999;702-709
17. Tohen M., Jacobs T.G., Grundy S.L., McElroy S.L., Banov M.C., Janicak P.G., Sanger T., Risser R., Zhang F., Toma V., Francis J., Tollefson G.D., Breier A. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch. Gen. Psychiatry. 157:2002;841-849
18. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity, and sensitivity. Br. J. Psychiatry. 133:1978;429-435
19. Zimmerman M., Mattia J.D., Posternak M.A. Are subjects in pharmacologica treatment trials of depression representative of patients in routine clinical practice? Am. J. Psychiatry. 159:2002;469-473